Mouse models have shown that CAF01 induces a Th1- and Th17-biased CD4 T cell response combined with a humoral immune response [3] and confers protective immunity against tuberculosis (TB) in mice, guinea pig and non-human primate models when formulated with antigens from Mycobacterium tuberculosis [4–6]. Here, CD4 is linked to tuberculosis.